Climate change is now central to many national and international political and legislative agendas: businesses must take this into account in planning strategically.

This report is a summary of and a response to that rapidly changing picture. It takes account of recent events, including the failed international initiative at Copenhagen in 2009: and it proposes a framework and approach for businesses seeking to get this issue right, without tying themselves down with open-ended spending obligations.

Scope of this research
• Newly developed framework tool enabling companies to evaluate their own corporate social responsibility achievements
• Overview of political and legislative tools available to governments seeking to regulate corporate energy use
• Recommendations for future policy: balancing consumer demand, regulatory pressure and business need
• Principles of brand and marketing in a world attuned to corporate social responsibility
• Case studies covering corporate initiatives by business sector and by business focus

Research and analysis highlights

Climate change is now central to many national and international political and legislative agendas: businesses must take this into account in planning strategically.

Consumer response to climate change is far less homogenous than believed: in addition to being inconsistent and ill-informed, there is a distinct consumer segment that actively resists business “over-reaction” in this area, penalising those businesses believed to be adding cost unnecessarily through csr programmes.

Business solutions need to take account of the fact that their CO2 emissions are the result of complex interactions between inter-locking areas in business: change needs to be considered holistically (to ensure that improvement in one area is not wiped out by worse performance in another).

Key reasons to purchase this research
• What are the key issues driving the development of corporate social responsibility initiatives?
• How can business evaluate their own performance in this area? Where can they go for assistance?
• What is the downside to CSR, both in terms of failure to adapt (under-performance) and taking it up too enthusiastically (over-delivery)?
• What are some of the key areas where businesses need to review their CSR performance?
• What are the “quick win” areas? Review of consumer attitudes in the area of environmental friendliness

To know more about this report & to buy a copy please visit:
http://www.visionshopsters.com/product/16207/Corporate-Carbon-Strategies-Threats-and-opportunities-arising-from-the-new-energy-imperative.html

As the U.S. economy slid deeper into recession during 2009, coffee marketers and foodservice operators moved in the opposite direction, digging out of the trench of 2008 with a variety of strategies designed to capitalize on the fact that even upscale coffee is a relatively thrifty luxury that offers comfort during stressful times. Two success stories were the rebound of Starbucks on the foodservice side and the revitalization of the former P&G retail coffee portfolio by J M. Smucker. Although the era when the coffee market grew effortlessly through premiumization may have ended, such upscale trends as the shifts towards specialty coffee beverages, gourmet beans and ethical consumerism are still clearly in force. What’s more, there’s ample opportunity for companies to capitalize on such trends as the economy recovers—not by ignoring the tougher times or reversing strategy, but by crafting an image that’s both upscale and responsive to consumers’ stronger-than-ever demand for value.

Packaged Facts’ Coffee and Ready-to-Drink Coffee in the U.S.: The Market and Opportunities in Retail and Foodservice, 6th Edition offers a comprehensive look at this $47.5 billion market, examining both the retail and foodservice sides of the business as well as the growing overlap of the two. On the retail side, the report analyzes coffee sold for future brewing—beans and ground, and instant—as well as RTD coffee drinks (à la Frappuccinos), as well as coffee enthusiast’s new brewing method of choice: single-serve (pod) coffee. Positive upscaling trends that slowed during the weak economy will gradually regain the upper hand, the report predicts, resulting in increasing annual percentage sales gains lifting sales by 23% by 2014 to reach $58.3 billion. The report examines sales across the entire retail universe, using Information Resources, Inc. InfoScan Review data and SPINSscan data to extensively chart performance, market composition and marketer/brand performance for the mass-market and natural supermarket channels.

Comprehensive coverage is also devoted to the vast foodservice market for coffee, including the expansion of specialty drinks at such mass-market venues as McDonalds, Dunkin’ Donuts and, most recently, Burger King with its planned 2010 roll-out of Starbucks’ Seattle’s Best. Supplementing the market tracking and forecasting of previous editions, Coffee and Ready-to-Drink Coffee in the U.S.: The Market and Opportunities in Retail and Foodservice, 6th Edition pays special attention to trends in new product development, inclusive of valuable global perspective; details competitive opportunities, including via in-depth company profiles; explores winning marketing methods including Web-based activity; and provides detailed consumer profiling using Experian Simmons data for 2009.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2217/Coffee-and-Ready-to-Drink-Coffee-in-the-U-S-The-Market-and-Opportunities-in-Retail-and-Foodservice-6th-Edition.html

Contact us:

Visionshopsters
Ph : 91-22-40583020
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in France. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields, refineries, pipelines and storage terminals) in France. The report also analyses the fiscal regime relevant to the crude oil assets in France and compares the investment environment in France with other countries in the region. The profiles of the major companies operating in the crude oil sector in France together with the latest news and deals are also included in the report.

Scope

• Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 1996-2020.
• Historical and forecast data and information for all the major oil fields, refineries, pipelines and storage terminals in France for the period 2000-2013.
• Operator and equity details for major crude oil assets in France.
• Key information relating to market regulations, key energy assets and the key companies operating in the France’s energy industry.
• Detailed information on key fiscal terms (such as rents, bonuses, royalty, cost recovery, profit oil, petroleum and corporate taxes) pertaining the geography is also provided. A sample calculation detailing how fiscal terms apply to a typical asset in the regime is included.
• Information on the top companies in the France including business description, strategic analysis, and financial information. Key companies covered include TOTAL S.A, Exxon Mobil Corporation,
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy

• Gain a strong understanding France’s oil market.
• Facilitate market analysis and forecasting of future industry trends.
• Evaluate the attractiveness of this geography for oil investment in the light of government policies and the fiscal environment.
• Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.
• Understand the policies and fiscal terms, and their impact on contractor’s profits from upstream oil assets.
• Assess your competitor’s major crude oil assets and their performance.
• Analyze the latest news and financial deals in the oil sector in France.
• Develop strategies based on the latest operational, financial, and regulatory events.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
• Identify and analyze the strengths and weaknesses of the leading companies the French oil market.

Companies Mentioned

Gaz de France
TOTAL S.A.
Exxon Mobil Corporation

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3158/France-Oil-Markets-2010-Investment-Opportunities-Market-Analysis-and-Forecasts-to-2020.html
———————————————-

Summary

The leading business intelligence provider, has released its latest report “Renewable Energy Investment Opportunities in Emerging Economies” that gives an in-depth analysis of the emerging economies as upcoming renewable energy hotspots and provides investment forecasts up to 2015. The research analyzes the growth, evolution and investments in renewable energy market in emerging countries of the world. The study identifies potential hotspots for renewable energy investments in the world and analyzes the investment trends in emerging markets. The study provides a detailed analysis and investment forecasts in key emerging countries namely, China, India and Brazil. The report also provides a detailed analysis of financial investments by deal type in key emerging countries.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Detailed qualitative analysis of the market scenario and analysis of key emerging countries.
- Historical and forecast investments from 2001 to 2015
- Analysis of key countries such as China, India and Brazil
- Trend analysis by major deal type.
- Policy and regulatory framework governing the market
- Data sourced from proprietary database and extensive primary interviews with key participants across the value chain

Reasons to buy

- The report will enhance the decision making capability of the user in a more rapid and time sensitive manner.
- It will allow you to:Identify key growth and investment opportunities in renewable power market in the emerging economies
- Identify key partners and business development avenues
- Position yourself to gain the maximum advantage of the industry’s growth potential by developing strategies based on the latest operational and regulatory events
- Identify key strengths and weaknesses of important renewable energy investment destination in the emerging markets
- Facilitate decision-making based on strong historic and forecast data

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2143/Renewable-Energy-Investment-Opportunities-in-Emerging-Economies.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 – Growing Demand Drives Investment in Capacity”. The study, which is an offering from the company’s Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regions – Europe, North America and Asia Pacific. The factors that drive and restrain the growth of the HPAPIs market are also analyzed in the report. In addition, the research provides market share analysis of the leading HPAPIs producers for major regions. The market for HPAPIs is also analyzed based on the product types and therapeutic applications at a global level. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

- HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
- HPAPIs in key regions – Europe, North America and Asia Pacific.
- Coverage of the product types and therapeutic applications of the global HPAPIs market.
- Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
- Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the global HPAPIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the HPAPIs market.
- Identify macro and micro-economic trends shaping and driving the global HPAPIs market.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1964/The-Future-of-High-Potency-Active-Pharmaceutical-Ingredients-HPAPIs-Market-Forecasts-and-Growth-Opportunities-to-2015-Growing-Demand-Drives-Investment-in-Capacity.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 – Better and More Cost-Effective Treatment Options Create Opportunities”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global blood disorders market. The report analyzes the markets for blood disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets

Scope

The scope of this report includes:
- Annualized market data for the blood disorders market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments including anemia, thrombosis, hemophilia, neutropenia and thrombocytopenia
- Analysis of the blood disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the blood disorders market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are Amgen, Inc., Sanofi-Aventis, Bristol-Myers Squibb, Centocor Ortho Biotech Inc., and Baxter.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global blood disorders market

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

Amgen
Sanofi-Aventis
Bristol-Myers Squibb
Centocor Ortho Biotech Inc
Baxter

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1963/The-Future-of-Blood-Disorders-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Better-and-More-Cost-Effective-Treatment-Options-Create-Opportunities.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The report provides key information and analysis on the market opportunities in the clean technology industry. The report covers key market trends and growth forecasts for the wide range of clean technology industries that include energy generation, energy storage, energy infrastructure, energy efficiency, air, water, manufacturing/industrial, transportation, recycling & waste management, material management and agriculture. Deal landscape covers the deal analysis for each of the clean technology industry from 2005 to 2009. It also provides the analysis on the basis of geography and deal type for the year 2009. Global warming concerns and government legislations are constantly promoting the clean technology industries across globe. These advancements are expected to cause a significant growth in the demand for clean technologies in various industries.

Scope

- Market definition and the factors driving the clean technology industry.
- The report covers the market size and forecasts for the wide spectrum of clean technology industries that include energy generation, energy storage, energy infrastructure, energy efficiency, air, water, manufacturing/industrial, transportation, recycling and waste management, material management and agriculture.
- Annualized market revenues data from 2005 to 2009, forecast for 11 years to 2020.
- Investment landscape of the overall clean technology industry on the basis of geography and investment type in 2009
- Investment breakdown for each of the clean technology industries by geography and investment type for 2009

Reasons to buy

- Exploit growth opportunities in the wide range of clean technology industries.
- Develop business strategies by understanding the trends and developments that are driving the clean technology industry across globe.
- Devise market-entry and expansion strategies among the various clean technologies.
- What is the future demand potential of the clean technologies in various industries? – Identify, understand and capitalize.
- Make informed business decisions from the insightful and in-depth deal analysis for the various clean technology industries.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2144/The-Future-of-Clean-Technology-Markets-to-2020-Market-Forecasts-Deal-Analysis-and-Investment-Opportunities.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

http://www.visionshopsters.com/product/1134/Outsourcing-Opportunities-in-the-Medical-Device-2009-2014-.html

Medical devices form one of the largest industries in healthcare sector with an estimated size of $250 billion in 2009 and a growth rate of 6%-8%. The industry has been outsourcing medical device manufacturing services for almost a decade now. This trend has brought about huge profit margins, which has attracted many new players. Outsourcing has helped medical device manufacturers reduce product development cost by 10% to 30%. The services outsourcing industry has also gained from the entry of new medical device manufacturing companies, as these players lack experience in the field.

Orthopedic devices hold the largest market share and cardiology devices have the highest growth rate in the medical device manufacturing industry. The increasing regulations for class 2 and class 3 devices have increased the demand for regulatory consulting services. Growing complexities in supply chain and the need for efficient management of client accounts have increased the scope of product lifecycle management solution providers in the medical devices industry. Firms offering chip designing services have also benefitted from the increasing incidence of chronic diseases and the growing use of electronic and embedded systems in cardiovascular and neurology devices.

The report analyzes the outsourcing opportunities in cardiovascular, ophthalmic, oncology, dental, and neurology devices, along with a study of various tools used for developing, testing and simulation tools used for medical devices. The report categorizes the service outsourcing in medical device market as follows:

Services Market: Product design and development services, product testing and certification services, product implementation services, product maintenance services, product upgrade services and Regulatory consulting services for medical devices.

Applications Market: Class I Devices, Class II Devices and Class III Devices.

STAKEHOLDERS

The intended audience includes:

• Service outsourcing companies
• Medical devices manufacturers
• Consulting companies
• Financial institutions

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 4.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 200 patents and minimum 40 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – North America, Europe, Asia Pacific and ROW.
• We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices (five level of products) and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1134/Outsourcing-Opportunities-in-the-Medical-Device-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com